Akso Health Group

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Total Revenue $22.9m
$107.3m +367.96%
$61.3m -42.82%
$11.4m -81.36%
$1.8m -84.65%
$6.3m +259.62%
$13.2m +108.86%
$2.4m -81.68%
$14.8m +512.08%
$13.8m -6.40%
$13.8m 0.00%
Revenue from Contract with Customer, Including Assessed Tax $82.6m $19.0m $6.3m $13.2m
Cost of Revenue $13.7m
$31.4m +129.75%
$7.4m -76.43%
$5.0m -32.48%
$545k -89.10%
$5.4m +890.66%
$11.9m +120.81%
$2.3m -80.76%
$8.8m +284.20%
$13.8m +57.19%
$13.8m 0.00%
Net Interest Income ($804k)
$0 +100.00%
$0 $0
Gross Profit $22.9m
$107.3m +367.96%
$53.9m -49.72%
$6.9m -87.18%
$1.8m -74.62%
$916k -47.79%
$1.3m +38.50%
$122k -90.38%
($282k) -330.51%
($11k) +95.98%
($11k) 0.00%
Interest Income (Expense), Net $590k
Research and Development Expense $2.8m $1.2m $3.2m $441k $421k
Selling, General and Administrative Expense $2.6m $5.8m $9.9m $26.5m $27.2m $15.0m $15.5m $8.6m $3.6m $4.0m $4.0m
Marketing and Advertising Expense $11.9m $28.5m $2.8m $176k $6k $7k $168k
Sales and marketing $5.2m $15.2m $32.3m $16.5m $1.1m $241k $7k $168k
Amortization of Intangible Assets $2.1m
Operating Lease, Expense $2.0m $399k $467k $11k
Operating Expenses $13.0m $31.4m $10.9m $55.0m $32.7m $16.9m $15.5m $8.8m $166.0m $17.8m
Other Non Operating Income Expenses $57k $138k $34k ($4k)
Operating Income (Loss) $10.1m
$75.9m +651.76%
$5.1m -93.28%
($68.5m) -1444.27%
($30.9m) +54.90%
($15.9m) +48.43%
($14.3m) +10.48%
($8.6m) +39.45%
($166.3m) -1825.26%
($4.0m) +97.59%
($4.0m) 0.00%
Interest Expense $804k $0 $0 $0
Net Non Operating Interest Income Expense ($804k) $0 $0 $0
Foreign Currency Transaction Gain (Loss), before Tax ($592k) ($26)
Gain On Sale Of Security ($749k) $1.1m ($592k) ($26) $272 $272
Other Nonoperating Income (Expense) $661k $2.3m $1.6m ($165k) ($781k) $1.2m ($454k) ($162.3m) ($16.7m)
Nonoperating Income (Expense) $34k
Other expense ($19k) ($23k) ($29k) ($655k) ($265k) ($821k) ($338k) ($114k) ($13k)
Other Income Expense $661k $2.3m $1.6m ($165k) ($781k) $1.2m ($454k) ($162.3m) ($16.7m) ($16.7m)
Total Other Income (Expense), net $381k $1.2m ($165k) ($781k) $1.2m ($454k) $34k
Pre-Tax Income $10.1m $76.5m $7.4m ($66.9m) ($31.1m) ($16.7m) ($13.1m) ($9.1m) ($166.3m) ($20.7m) ($20.7m)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $10.1m $76.5m $7.4m ($66.9m) ($31.1m) ($16.7m) ($13.1m) ($9.1m) ($166.3m) ($20.7m) ($20.7m)
(BENEFIT) PROVISON FOR INCOME TAXES $1.5m $11.0m $1.9m $4.3m $483k $131k $18k $25k ($30.8m) ($2.0m)
Net loss from discontinued operations, net of income taxes $13.1m ($23.8m) ($6.4m) ($12.7m) $11.8m ($4k)
Loss from disposal of discontinued operations, net of income taxes $3.2m ($396k)
Current Income Tax Expense (Benefit) $10.6m $5.6m $684k $483k $131k $18k $25k $3k ($2.0m)
NET LOSS FROM CONTINUING OPERATIONS ($4.3m) ($4.1m) ($13.1m) ($9.1m) ($135.5m) ($18.7m)
NET LOSS $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.8m) ($1.2m) ($9.5m) ($135.5m) ($18.7m)
Net Income Continuous Operations ($4.3m) ($4.1m) ($13.1m) ($9.1m) ($135.5m) ($18.7m) ($18.7m)
Net Income Discontinuous Operations ($23.8m) ($3.3m) ($12.7m) $11.8m ($400k) $0 $0 $0
NET LOSS ATTRIBUTABLE TO AKSO’S SHAREHOLDERS $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m)
($18.7m) +86.17%
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.1m) ($135.0m) ($18.7m) ($18.7m)
Net Income (Loss) Available to Common Stockholders, Basic $8.6m
$65.5m +664.01%
$5.5m -91.55%
($71.2m) -1386.89%
($34.8m) ($16.9m)
($1.4m) +91.93%
($9.5m) -595.54%
($135.0m) -1327.01%
($18.7m) +86.17%
($18.7m) 0.00%
Net Income (Loss) Attributable to Noncontrolling Interest $29k $1k $112k ($58k) ($492k) ($18.7m)
Net Income Including Noncontrolling Interests $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.8m) ($1.2m) ($9.5m) ($135.5m) ($18.7m) ($18.7m)
Income (Loss) from Continuing Operations, Per Basic Share ($1) ($0) ($0) ($0) ($0)
Income (Loss) from Continuing Operations, Per Diluted Share ($1) ($0) ($0) ($0) ($0)
Earnings Per Share, Basic $0.20 $1.46 $0.11 ($1.46) ($0.71) ($0.28) ($0.02) ($0.07) ($0.16) ($0.03) ($0.48)
Earnings Per Share, Diluted $0.20 $1.37 $0.10 ($1.46) ($0.71) ($0.28) ($0.02) ($0.07) ($0.16) ($0.48)
Basic (in Shares) $42.3m $45.0m $48.7m $48.8m $48.8m $59.6m $68.6m $141.5m $855.3m $463.1m
Diluted (in Shares) $42.3m $47.7m $52.9m $48.8m $48.8m $59.6m $68.6m $141.5m $855.3m $463.1m
Weighted Average Number of Shares Outstanding, Basic $42.3m 45.0m 48.7m 48.8m 48.8m 59.6m 68.6m 141.5m 855.3m 463.1m
Basic Average Shares $22.9m $47.2m $285.1m $722.7m $463.1m
Diluted Average Shares $22.9m $47.2m $285.1m $722.7m $463.1m
Weighted Average Number of Shares Outstanding, Diluted $42.3m 47.7m 52.9m 48.8m 48.8m 59.6m 68.6m 141.5m 855.3m 463.1m
Additional Financial Items
Costs and Expenses $56.2m $80.0m $32.7m
Goodwill, Impairment Loss $41.4m $16.7m
LOSS FROM CONTINUING OPERATIONS $9.9m $75.9m $5.1m ($68.5m) ($30.9m) ($15.9m) ($14.3m) ($8.6m) ($166.3m)
Exchange (loss) gain ($749k) $1.1m ($592k) ($26) $272
Less: net (loss) income attributable to non-controlling interest $29k $1k $112k ($58k) ($492k)
Foreign currency translation adjustment ($1.1m) $6.0m ($6.1m) ($5.3m) $3.9m $1.5m ($2.2m) ($239k) $312k
COMPREHENSIVE (LOSS) $7.5m $71.5m ($604k) ($76.5m) ($30.9m) ($15.4m) ($3.4m) ($9.8m) ($135.2m)
Less: comprehensive income (loss) attributable to non-controlling interest $133k $17 ($261) $391 ($3k)
COMPREHENSIVE (LOSS) ATTRIBUTABLE TO AKSO’S SHAREHOLDERS $7.5m $71.4m ($604k) ($76.5m) ($30.9m) ($15.4m) ($3.4m) ($9.8m) ($135.2m)
Diluted EPS ($0.06) ($0.21) ($0.48) ($0.03) ($0.48)
Diluted NI Availto Com Stockholders $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m) ($18.7m) ($18.7m)
Excise Taxes $5k $2k $4k $3k $3k
Impairment Of Capital Assets $0 $0 $162.4m $16.7m $16.7m
Minority Interests ($112k) $58k $492k $45k $45k
Normalized EBITDA ($15.4m) ($8.0m) $160.6m $15.1m ($1.6m)
Normalized Income ($14.1m) ($8.6m) ($2.6m) ($3.6m) ($3.6m)
Operating Expense $15.5m $8.8m $3.6m $4.0m $4.0m
Other Gand A $2.6m $5.8m $9.9m $26.5m $27.2m $15.0m $15.5m $8.6m $3.6m $4.0m
Reconciled Depreciation $0 $0 $2.1m $2.4m $2.4m
Salaries And Wages $392k $0 $0 $0
Selling General And Administration $15.5m $8.8m $3.6m $4.0m
Special Income Charges $0 $0 ($162.4m) ($16.7m) ($16.7m)
Tax Effect Of Unusual Items $286k ($148k) ($30.0m) ($1.6m) ($1.6m)
Tax Provision $1.5m $11.0m $1.9m $4.3m $483k $131k $18k $25k ($30.8m) ($2.0m) ($2.0m)
Tax Rate For Calcs $0 $0 $0 $0 $0
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax ($6.4m) $11.8m ($4k)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($16.9m) ($13.1m) ($9.1m) ($135.5m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($31.6m) ($16.8m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $11.8m ($400k)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($3.3m) $11.8m
Total (loss) gain from discontinued operations ($23.8m) ($3.3m) ($12.7m) $11.8m ($400k) $0 $0
Total Expenses $27.4m $11.1m $18.7m $17.8m $17.8m
Total Unusual Items $1.1m ($592k) ($162.4m) ($16.7m) ($16.7m)